King Hussein Cancer Center
Jordan’s King Hussein Cancer Center recently doubled its capacity to provide leading-edge treatment to one of the world’s most deadly diseases Writer: Tom Wadlow Project Manager: Callam Waller Cancer – one of the most high-profile illnesses and second leading cause of death in the world. The World Health Organization (WHO) estimates that the disease will be responsible for 9.6 million deaths this year, or one in six mortalities. Arrow in on low- and middle-income nations, and you will find that 70 percent of all cancer deaths occur in these countries. There is also an enormous economic impact associated with the condition – the total annual economic cost of cancer in 2010 was estimated at approximately $1.16 trillion, a figure which is rising. In the Middle East, the WHO predicts that cancer cases will double by 2030. If the region, and indeed the world is to tackle this growing threat, then the work carried out by the likes of Jordan’s King Hussein Cancer Center (KHCC) is going to be vital. Established by Royal decree back in 1997, Amman-based KHCC now treats more than 60 percent of all cancer cases in Jordan, with survival rates comparable to anywhere else in the developed world. Developed in collaboration with leading institutions from around the world, the centre’s clinical cross-departmental services cover: breast cancer, gastrointestinal malignancies clinic, adult lymphoma, head and neck, thoracic, gynaecological malignancies, sarcoma, adult neuro-oncology, genitourinary malignancies, thyroid, adult leukaemia, adult ocular oncology, paediatrics solid tumours, paediatric neuro-oncology, and paediatric leukaemia services. Such work will continue to be…
King Hussein Cancer Centre
King Hussein Cancer Centre is a leading facility in the developing world, breaking new ground in the Middle East in the pursuit not only of internal excellence, but of improved regional healthcare Writer:Matthew Staff Project Manager:Callam Waller In just 20 years, the King Hussein Cancer Foundation and Centre has grown from a hospital comprising just two full-time oncologists to be one of Jordan’s, and indeed the region’s, leading non-profit healthcare institutions with more than 250 consultants and oncologists to call upon. Established by Royal decree back in 1997, the institution has evolved exponentially not just from a capacity perspective, but in the quality of care offered and across the research & development carried out. The result: King Hussein Cancer Centre (KHCC) now treats more than 60 percent of all cancer cases in Jordan, with survival rates comparable to anywhere else in the developed world. “KHCC is the only specialised tertiary hospital that provides all treatment modalities and services for cancer care in addition to bone marrow transplantation for adult and paediatric patients in Jordan,” elaborates the Centre’s Chief Executive Officer and Director General, Dr Asem Mansour. “It has developed its organisational structure from mere medical and non-medical departments, to include cross-departmental units and programmes that focus on specific cancers. “This is referred to as multidisciplinary management of cancer patients and is practiced continuously at KHCC through multidisciplinary organised teams (MDT) or clinics (MDC).” Developing in collaboration with leading institutions from around the world, KHCC’s clinical cross-departmental services include: breast cancer, gastrointestinal malignancies clinic, adult…
